Ftse Mib
33.569,87
1,05%
DAX
18.168,59
0,56%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
66.387,85
2,19%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Cipher Pharmaceuticals Inc (CPH) Cipher Pharmaceuticals Inc (CPH) Notizie

CPH

Cipher Pharmaceuticals (CPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:CPH
DataOraFonteTitoloSimboloCompagnia
14/06/202418:46PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of ShareholdersTSX:CPHCipher Pharmaceuticals Inc
09/05/202423:00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter 2024 ResultsTSX:CPHCipher Pharmaceuticals Inc
03/05/202413:05PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
14/03/202422:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ResultsTSX:CPHCipher Pharmaceuticals Inc
08/03/202413:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
29/01/202418:56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202418:56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Shares of this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202413:15PR Newswire (Canada)Cipher Pharmaceuticals Announces the Commencement of OTCQX TradingTSX:CPHCipher Pharmaceuticals Inc
24/11/202323:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Change of AuditorTSX:CPHCipher Pharmaceuticals Inc
15/11/202323:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Normal Course Issuer BidTSX:CPHCipher Pharmaceuticals Inc
09/11/202323:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023TSX:CPHCipher Pharmaceuticals Inc
27/10/202313:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
12/10/202315:57PR Newswire (Canada)Cipher Pharmaceuticals Announces Final Results of Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
03/10/202313:00PR Newswire (Canada)Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
05/09/202313:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian DollarsTSX:CPHCipher Pharmaceuticals Inc
10/08/202323:00PR Newswire (Canada)Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in MexicoTSX:CPHCipher Pharmaceuticals Inc
28/07/202313:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
05/07/202313:00PR Newswire (Canada)Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European UnionTSX:CPHCipher Pharmaceuticals Inc
11/05/202323:00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial FlexibilityTSX:CPHCipher Pharmaceuticals Inc
04/05/202323:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
16/03/202322:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
10/03/202323:30PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
01/03/202313:00PR Newswire (Canada)Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit FacilityTSX:CPHCipher Pharmaceuticals Inc
11/11/202200:30PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per ShareTSX:CPHCipher Pharmaceuticals Inc
26/10/202213:00PR Newswire (Canada)CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALLTSX:CPHCipher Pharmaceuticals Inc
11/08/202223:45PR Newswire (Canada)Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFOTSX:CPHCipher Pharmaceuticals Inc
11/08/202223:01PR Newswire (Canada)Cipher Pharmaceuticals Reports Second Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
05/08/202213:00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
22/06/202223:01PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John MullTSX:CPHCipher Pharmaceuticals Inc
12/05/202223:00PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:CPH

La tua Cronologia

TG
XS5E
Deutsche Bank Luxembourg
LSE
ZR63
Citi Fun 24
BIT
P20SN6
NLBNPIT20SN6 20240920 190
LBNK
AGIXUSDT
SingularityNET Token
USOTC
GSKKF
Abitibi Metals (PK)
NYSE
BAC-L
Bank of America
NYSE
CIA
Citizens
USOTC
SBRKF
Sparebank 1 Sr Bk ASA (PK)
NYSE
USB-M
US Bancorp
LSE
HUME
ASX
DA8HB
Driver Australia Eight
LSE
RD86
Hsbc Bk.23
NASDAQ
BYRN
Byrna Technologies
BIT
UC72MC
Unicredit Bank
BIT
P204Z0
NLBNPIT204Z0 20241220 14
TG
1VIC
1Valor Internet Comptr P...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network